Advances in mRNA manufacturing
The success of SARS-CoV-2 mRNA vaccines marked a pivotal shift in the biopharmaceutical landscape, accelerating innovation and adoption of mRNA technologies. In response to global demand, the mRNA manufacturing industry has rapidly advanced in both its technological capabilities and production infrastructure. These developments are not only optimizing current processes but are also paving the way for a new generation of mRNA-based therapies targeting a wide range of diseases.
This dedicated feature page offers expertly supported resources for professionals navigating this evolving mRNA manufacturing landscape. Explore in-depth articles, curated resources, and the latest industry news designed to support your decision-making and inspire continued progress in mRNA manufacturing.
Assessing mRNA capping efficiency and Poly(A) tail length with simple electrophoretic separation
Discover CELLSCRIPT™ kits that assess mRNA quality attributes to meet USP guidelines and enable scientists to obtain reliable, same-day results.
Download resource
Overcome common hurdles in scaling up mRNA-based therapeutics
Explore ways to resolve three of the key challenges in the field of mRNA-based therapies to unlock the full potential of these therapies.
View article
Advance therapeutic development with mRNA manufacturing solutions
Download this eBook to explore an integrated manufacturing workflow that spans from codon-optimized genes to mRNA production to Lipid Nanoparticle (LNP) delivery.
Download resource
